✦ LIBER ✦

Phase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer

✍ Scribed by Tsuda, H; Hashiguchi, Y; Nishimura, S; Miyama, M; Nakata, S; Kawamura, N; Negoro, S

Book ID: 109998221
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 101 KB
Volume: 91
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602076

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irinotecan and infus

A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Suguru Machida; Takeshi Yoshida; Munehide Yoshida; Yasuliko Kano; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 68 KB

A phase I study of irinotecan and infusi

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

✍ K. Mori; T. Hirose; S. Machida; K. Yokoyama; K. Tominaga 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 275 KB

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

Phase II study of cisplatin as a 5-day c

Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer

✍ Yoshikuni Saito; Kiyoshi Mori; Keigo Tominaga; Kouhei Yokoi; Naoto Miyazawa 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 500 KB

Phase II study of intensive chemotherapy

Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer

✍ Giorgio Vittorio Scagliotti; Umberto Ricardi; Lucio Crinó; Ernesto Maranzano; Fi 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 375 KB

A Phase II Double-Blind Randomized Study

A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

✍ Howard Hochster; James L. Speyer; John P. Mandeli; Carolyn Runowicz; Scott Wadle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB